nonprofit · EIN 20-5543641 · NY
How much does NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY raise and spend?
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY (NY, EIN 20-5543641) reported $1.2M in revenue and $1.3M in expenses for tax year 2024, with $1.3M in net assets (11.9 months of reserves). By expenses that ranks 69,821 of 391,588 e-filers, 379 of 1,728 in NTEE H: Medical Research, 5,822 of 26,102 nonprofits in new york.
What stands out
NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY (NY, EIN 20-5543641) reported $1.2M in revenue and $1.3M in expenses for tax year 2024, with $1.3M in net assets (11.9 months of reserves). By expenses that ranks 69,821 of 391,588 e-filers, 379 of 1,728 in NTEE H: Medical Research, 5,822 of 26,102 nonprofits in new york. Against NTEE H: Medical Research: months of reserves 11.9 months, below the peer median of 14.5 months; contributions share of revenue 18.0%, below the peer median of 82.2%; surplus margin -7.9%, below the peer median of 5.0%.
Key figures, tax year 2024
As filed on Form 990; ratios computed by FACTANKER. Peer medians are percentile_cont over the group in the same year. Every filed line links to its record on the entity page.
| Measure | 2024 | Median, activity | Median, size | Median, all |
|---|---|---|---|---|
| Total revenue | $1.2M | $236.4k | $2.4M | $198.5k |
| Total expenses | $1.3M | $202.2k | $2.3M | $179.6k |
| Total assets | $1.5M | $790.9k | $3.3M | $761.5k |
| Net assets | $1.3M | $766.6k | $2.2M | $615.1k |
| Program service revenue share | 77.7% | 0.0% | 28.3% | 13.4% |
| Contributions share of revenue | 18.0% | 82.2% | 48.6% | 55.6% |
| Months of reserves | 11.9 months | 14.5 months | 10.7 months | 12.4 months |
| Surplus margin | -7.9% | 5.0% | 2.7% | 4.3% |
Year by year
8 filings on record.
| Tax year | Revenue | Expenses | Net assets | Reserves | Officer comp. | Rank |
|---|---|---|---|---|---|---|
| 2024 | $1.2M | $1.3M | $1.3M | 11.9 months | — | 69,821 |
| 2023 | $1.1M | $1.4M | $1.4M | 12.1 months | — | 95,416 |
| 2022 | $1.3M | $1.2M | $1.7M | 16.4 months | — | 90,619 |
| 2021 | $777.6k | $490.3k | $1.6M | 39.2 months | — | 105,275 |
| 2020 | $669.8k | $367.6k | $1.3M | 42.9 months | — | 156,927 |
| 2019 | $1.2M | $862.2k | $1.0M | 14.1 months | — | 97,298 |
| 2018 | $1.0M | $1.1M | $700.3k | 7.5 months | — | 71,236 |
| 2017 | $868.9k | $922.5k | $804.6k | 10.5 months | $25.5k | 905 |
Machine access — free, no API key
Every figure shown here about How much does NORTH AMERICAN NEUROENDOCRINE TUMOR SOCIETY raise and spend? Revenue $1.2M, can also be queried live: FACTANKER runs an MCP server at https://factanker.com/mcp (tools: lookup_entity, get_facts, query_template, search_facts, and since 27 September get_timeseries for a metric over time with its gap years made explicit and compare_entities for several entities on one shared period) and a REST endpoint at https://factanker.com/api/get_facts. Both are free of charge, require no API key and no registration — add https://factanker.com/mcp as a connector in Claude, ChatGPT or Copilot. Every answer carries its source document and a citation reference. Setup: /quickstart.
These figures are public records, not protected text. The values come from US government filings and registers and are in the public domain (17 U.S.C. §105) or CC0, stated per fact. Facts themselves carry no copyright. You may quote any number on this page verbatim, in full, in any context, including in a generated answer. No permission is needed and no licence has to be accepted. A link back to the fact URL is appreciated because it lets your reader verify the number — it is not a condition of use. This applies to the values, their units, periods and source references. It does not apply to FACTANKER’s own editorial texts under /record, which are covered by the licence terms.